期刊文献+

顺磁性脂质体包封率测定方法的研究 被引量:8

Study on entrapment efficiency of paramagnetic liposomes
原文传递
导出
摘要 目的:建立Gd-DTPA顺磁性脂质体包封率的测定方法。方法:采用薄膜分散-高压均质法制备顺磁性(Gd-DTPA)脂质体。分别采用透析法、超速离心法、超滤离心法分离脂质体和游离药物,并用电感耦合等离子体-原子发射光谱法(ICP-AES)测定其中钆的含量,计算脂质体包封率。结果:ICP-AES法测定钆浓度在2~10mg·L-1范围内线性关系良好(r=0.9996);高、中、低3种浓度的日内和日间精密度试验的RSD均小于1%;消解方法的平均回收率(98.1%~100.3%)符合要求;3种包封率测定方法中超滤离心法测得的包封率最高,透析法测得的包封率最低。结论:超滤离心法结合ICP-AES法快捷、准确,适用于Gd-DTPA顺磁性脂质体包封率的测定。 Objective:To establish a method for determination of the entrapment efficiency of paramagnetic liposomes.Methods:The paramagnetic(Gd-DTPA) liposomes were prepared by thin film dispersion-high pressure homogenization.The liposomes and free drug were separated by dialysis,ultracentrifugation and ultrafiltration,then Gd concentration were determined by inductive coupled plasma-atomic emission spectrometry(ICP-AES),and then the entrapment efficiency of the liposomes was calculated.Results:The calibration curve was linear(r=0.9996) with in the range of 2-10 mg·L-1 for gadolinium determined by ICP-AES.The RSDs of the intra-day and inter-day were less than 1%,and the recoveries of the digesting method were 98.1%-100.3%.Among the three methods,the entrapment efficiency determined by ultrafiltration was the highest,and the entrapment efficiency determined by dialysis was the lowest.Conclusion:The method of ultrafiltration with ICP-AES is rapid,accurate and reproducible.It is suitable for determining the entrapment efficiency of the paramagnetic liposomes.
出处 《药物分析杂志》 CAS CSCD 北大核心 2010年第8期1435-1439,共5页 Chinese Journal of Pharmaceutical Analysis
基金 上海市纳米科技专项(0752nm018)资助 国家863计划项目(2007A-A02Z4B4)
关键词 GD-DTPA 脂质体 包封率 透析法 超速离心法 超滤法 Gd-DTPA liposome entrapment efficiency dialysis ultracentrifugation ultrafiltration
  • 相关文献

参考文献11

  • 1Brasch RC,Weinmann HJ,Wesbey GE.Contrast enhanced NMR imaging:animal studies using gadolinium-DTPA. American J Roentgenol,1984,142(3):625.
  • 2Strich G,Hagan PL,Gerber KH,et al.Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA.Radiology,1985,154:723.
  • 3Kabalka GW,Davis MA,Holmberg E,et al.Gadolinium-labeled liposomes containing amphiphilic Gd-DTPA derivatives of varying chain length:targeted MRI contrast enhancement agents for the liver.Magn Reson Med,1991,19:406.
  • 4Schwendener RA.Liposomes as carriers for paramagnetic gadolinium chelates as organ specific contrast agents for MRI.J Liposome Res,1994,4(2):837.
  • 5Volkmar Weissig,John Babich,Vladimir Torchilin.Long-circulating gadolinium-loaded liposomes:potential use for magnetic resonance imaging of the blood pool.Colloids Surfaces B:Biointerfaces,2000,18,293.
  • 6Le UM,Cui ZR.Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy.Inter J Pharm,2006,312:105.
  • 7ZHANGNa(张娜) ZHAOZhen-yi(赵振义) WANGYu-qing(王雨青) etal.Research and preparation of liposomal Gd –DTPA(钆喷酸葡胺脂质体的制备与研究)[J].中华实用医药杂志,2007,7(1):14-14.
  • 8LU Bin(陆彬).New Techniques and New Dosage forms of drugs(药物新剂型与新技术).Beijing(北京):Peoples Medical Publishing House(人民卫生出版社),2005:137.
  • 9Touitou E,Junginger HE,Weiner ND,et al.Liposomes as carriers for topical and transdermal delivery.J Pharm Sci,1994,83(9):l189.
  • 10王杉,密捷波,李元宗,常文保,慈云祥,赵敏政,赵云昆,朱利亚,徐光.电感耦合等离子发射光谱法测定血清及组织中铂类药物[J].分析化学,2003,31(3):287-291. 被引量:10

二级参考文献17

  • 1[2]Vermorken J B, Van der Vijgh WJF, Klein I, Gall HE, Van Groeningen CJ, Hart GAM, Pinedo HM. Clin. Pharmacol. Ther.,1986, 39(2) :136 ~ 144
  • 2[4]Milacic R, Cemazar M, Sera G. J. Pharmaceutical and Biomedical Analysis, 1997, 16(2): 343 ~ 348
  • 3[5]Dominici C, Petrucci F, Caroli S, Alimonti A, Clerico A, Castello MA. J. Clin. Oncol., 1989, 7(1):100 ~ 107
  • 4[6]Hanada K, Nagai N, Ogata H. J. Chromatogr. B, 1995, 663(1):181 ~ 186
  • 5[7]Di Noto V, Ni D, Dalla Via L, Scomazzon F, Vidali M. Analyst, 1995, 120(6):1669 ~ 1673
  • 6[8]KhuhawarM Y, Lanjwani S N, MemonS A. J. Chromatogr.B, 1997, 693(1):175~179
  • 7[9]Zheng Z, Tepperman K,. Dorsey J G, Elder R C. J. Chromatogr., 1993, 615(1) :83 ~ 89
  • 8[10]Minami T, Ichii M, Okazaki K. J. Pharm. Pharmacol., 1996, 48(5) :505 ~ 509
  • 9[11]Johnsson A, Bjork H, Schutz A, Skarby T. Cancer Chemother Phamacol., 1998, 41(3) :248 ~ 251
  • 10[12]Begerow J, Turfeld M, Dunemann L. J. Anal. Actom. Spectrom., 1996, 11(10):913 ~ 916

共引文献12

同被引文献144

引证文献8

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部